Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 969-976

  Jin, Hongkui ^a   Li, Bing ^a   Cunningham, Brian ^a   Tom, Jeffrey ^a   Yang, Renhui ^a   Sehl, Patricia ^a   Thomas, G Roger ^a   Ko, Annie ^a   Oare, David ^a   Lowe, David G ^a  

^a GENENTECH INC   (United States)

Author keywords

atrial natriuretic peptide; cGMP; diuresis; natriuresis; phage display

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DIURESIS; DRUG CLEARANCE; DRUG RECEPTOR BINDING; IMMUNOPATHOLOGY; NATRIURESIS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 9544224165     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118881     Document Type: Article

References (34)

1. Brenner, B.M., B.J. Ballermann, M.E. Gunning, and M.L. Zeidel. 1990. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70:665-699.
2. John, S.W.M., J.H. Krege, P.M. Oliver, J.R. Hagaman, J.B. Hodgin, S.C. Pang, T.G. Flynn, and O. Smithies. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science (Wash. DC). 267:679-681.
3. Steinhelper, M.E., K.L. Cochrane, and L.J. Field. 1990. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension (Dallas). 16:301-307.
4. Ruskoaho, H. 1993. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol. Rev. 44:479-602.
5. Wilkins, M.R., S.L. Settle, and P. Needleman. 1990. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3′,5′-cyclic monophosphate degradation. J. Clin. Invest. 85: 1274-1279.
6. Murad, F. 1986. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1-5.
7. Chinkers, M., D.L. Garbers, M.-S. Chang, D.G. Lowe, H. Chin, D.V. Goeddel, and S. Schulz. 1989. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (Lond.). 338:78-83.
8. Lowe, D.G., M.S. Chang, R. Hellmiss, E. Chen, S. Singh, D.L. Garbers, and D.V. Goeddel. 1989. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. Eur. Mol. Biol. Org. J. 8:1377-1384.
9. Wilcox, J.N., A. Augustine, D.V. Goeddel, and D.G. Lowe. 1991. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol. Cell. Biol. 11:3454-3462.
10. Sarzani, R., V.M. Paci, P. Dessì-Fulgheri, E. Espinosa, and A. Rappelli. 1993. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J. Hypertens. 11:S214-S215.
11. Porter, J.G., A. Arfsten, F. Fuller, J.A. Miller, L.C. Gregory, and J.A. Lewicki. 1990. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem. Biophys. Res. Commun. 171:796-803.
12. Maack, T. 1992. Receptors of atrial natriuretic factor. Annu. Rev. Physiol. 54:11-27.
13. Maack, T., M. Suzuki, F.A. Almeida, D. Nussenzveig, R.M. Scarborough, J.A. McEnroe, and J.A. Lewicki. 1987. Physiological role of silent receptors of atrial natriuretic factor. Science (Wash. DC). 238:675-678.
14. Anand-Srivastava, M.B., and G.J. Trachte. 1993. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45:455-497.
15. Rutherford, R.A.D., J. Wharton, P. Needleman, and J.M. Polak. 1991. Autoradiographic discrimination of brain and atrial natriuretic peptide-binding sites in the rat kidney. J. Biol. Chem. 266:5819-5826.
16. Cunningham, B.C., D.G. Lowe, B. Li, B.D. Bennett, and J.A. Wells. 1994. Production of an atrial natriuretic peptide variant that is specific for type A receptors. Eur. Mol. Biol. Org. J. 13:2508-2515.
17. Almeida, F.A., M. Suzuki, R.M. Scarborough, J.A. Lewicki, and T. Maack. 1989. Clearance function of type C receptors of atrial natriuretic factor in rats. Am. J. Physiol. 256:R469-R475.
18. Okolicany, J., G.A. McEnroe, G.Y. Koh, J.A. Lewicki, and T. Maack. 1992. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J. Physiol. 263:F546-F553.
19. Engel, A., J.R. Schoenfeld, and D.G. Lowe. 1994. A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. J. Biol. Chem. 269:17005-17008.
20. Bennett, B.D., G.L. Bennett, R.V. Vitangcol, J.R.S. Jewett, J. Burnier, W. Henzel, and D.G. Lowe. 1991. Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. J. Biol. Chem. 266:23060-23067.
21. Li, B., J.Y.K. Tom, D. Oare, R. Yen, W. Fairbrother, J.A. Wells, and B.C. Cunningham. 1995. Minimization of a polypeptide hormone. Science (Wash. DC). 270:1657-1660.
22. Schoenfeld, J.R., P. Sehl, C. Quan, J.P. Burnier, and D.G. Lowe. 1995. Agonist selectivity for three species of natriuretic peptide receptor-A. Mol. Pharmacol. 47:172-180.
23. Kenny, A.J., A. Bourne, and J. Ingram. 1993. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem. J. 291:83-88.
24. Koller, K.J., D.G. Lowe, G.L. Bennett, N. Minamino, K. Kangawa, H. Matsuo, and D.V. Goeddel. 1991. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science (Wash. DC). 252: 120-123.
25. Munson, P.J., and D. Rodbard. 1980. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
26. Furchgott, R., and J. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
27. Jin, H., C. Mathews, Y.-F. Chen, R. Yang, J.M. Wyss, P. Esunge, and S. Oparil. 1992. Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats. Am. J. Hypertens. 5:210-218.
28. Schultz, H.D., M.K. Steele, and D.G. Gardner. 1990. Central administration of atrial natriuretic peptide decreases sympathetic outflow in rats. Am. J. Physiol. 258:R1250-R1256.
29. Nussenzveig, D.R., J.A. Lewicki, and T. Maack. 1990. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J. Biol. Chem. 265:20952-20958.
30. Terada, Y., T. Moriyama, B.M. Martin, M.A. Knepper, and A. Garcia-Perez. 1991. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am. J. Physiol. 261:F1080-F1087.
31. Nonoguchi, H., M.A. Knepper, and V.C. Manganiello. 1987. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J. Clin. Invest. 79:500-507.
32. Chabardes, D., M. Montegut, M. Mistaoui, D. Butler, and F. Morel. 1987. Atrial natriuretic peptide effects on cGMP and cAMP contents in microdissected glomeruli and segments of the rat and rabbit nephrons. Pflugers Arch. 408:366-372.
33. Koyama, S., T. Terai, T. Inoue, K. Inomata, K. Tamura, Y. Kobayashi, Y. Kyogoku, and M. Kobayashi. 1992. An oxidized analog of a-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase. Eur. J. Biochem. 203: 425-432.
34. Blaine, E.H., L.A. Heinel, T.W. Schorn, E.A. Marsh, and M.A. Whinnery. 1986. The character of the atrial natriuretic response: pressure and volume effects. J. Hyperten. 4:S17-S24.